A new procoagulant in acute leukemia

A. Falanga, M. G. Alessio, M. B. Donati, T. Barbui

Research output: Contribution to journalArticlepeer-review


To verify whether cancer procoagulant (CP), a cysteine proteinase procoagulant distinct from tissue factor (TF), is associated with leukemic cells, we assayed the procoagulant activity of blast cell extracts from 26 patients with different cytological subtypes of acute nonlymphoid leukemia (ANLL) according to the French-American-British classification. All the samples except two shortened the recalcification time of normal human plasma, the effect being significantly greater in the M3 subgroup. The two criteria used to distinguish between CP and TF, independence from factor VII in initiating blood coagulation and sensitivity to cysteine-proteinase inhibitors, were positive in 19 samples from M1, M2, M3, and M4 cytological subtypes. None of the M5 samples fulfilled these criteria. In addition, M1, M2, M3, and M4 samples immunoreacted with an anti-CP goat polyclonal antibody on an Ouchterlony immunodiffusion plate. This study provides the first evidence for a procoagulant other than TF that is associated with leukemic cells.

Original languageEnglish
Pages (from-to)870-875
Number of pages6
Issue number4
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'A new procoagulant in acute leukemia'. Together they form a unique fingerprint.

Cite this